To assess the impact of FOXO1 inhibition on MCL growth in vivo, control and FOXO1-targeted sgRNA-transduced CCMCL1 cells were transplanted via tail vein injection into secondary recipient NSG mice. This evidence concerns the gene FOXO1 and mantle cell lymphoma.